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Abstract 
Staphylococcus aureus is an increasing problem in clinical practice because of reduced susceptibility to available anti-
biotics. The objective of the study was to determine the frequency of Methicillin-resistant S. aureus (MRSA) in Pesha-
war, Pakistan. Clinical isolates of S. aureus were subjected to determination of antibiotic resistance, MICs and inducible 
clindamycin resistance (ICR). Out of total 280 S. aureus isolates, the frequency of MRSA was 36.1 % (n = 101). MRSA 
infection was found higher among the age group 50–59 years (60.71 %, OR 3.09), followed by 20–29 years (47.5 %, 
OR 1.74). Frequency of MRSA in female and male was 39.8 and 34 % respectively. MRSA was more frequent in blood 
specimens (48.7 %, OR 2.14). The frequency of community and hospital acquired MRSA was 42 and 34.8 % respec-
tively. MRSA showed high resistance (100 %) to penicillin and cefoxitin followed by erythromycin (99 %). While MRSA 
exhibited 100 % susceptibility to vancomycin and linezolid. We have also found 7 vancomycin intermediate sensitive 
S. aureus (VISA) isolates. ICR was observed in 15.84 % (n = 16) of MRSA isolates. It is concluded that MRSA is potential 
threat to public health in Peshawar. Vancomycin and linezolid could be prescribed as a drug of choice in treating 
MRSA associated infections. In addition, ICR should be routinely checked to avoid clindamycin treatment failure.
Keywords: Epidemiology, Drug resistance, S. aureus, MRSA, Peshawar
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Staphylococcus aureus (S. aureus) is a serious risk to 
public health as it causes human infections ranges from 
wound abscess to life threatening conditions (Deleo 
et al. 2010). Emergence of antibiotics resistant S. aureus 
especially Methicillin-resistant Staphylococcus aureus 
(MRSA) is a worldwide problem in both healthcare and 
community settings (Chambers and DeLeo 2009). MRSA 
can be transmitted from person to person via skin or the 
sharing of contaminated objects. In addition, MRSA can 
evade host immune system and virulence factors dissem-
inated render this bug with limited therapeutic options 
available (Holcomb et  al. 2008). MRSA have capabil-
ity to breed in the presence of methyl penicillin and its 
derivatives like methicillin. Resistance to methicillin is 
mediated by mec-A gene, which encodes the polypeptide 
PBP2a protein (Oliveira et al. 2006). The mec-A gene have 
also insertion sites for transposons and plasmids which 
assist resistance to other antibiotic groups. Accordingly, 
cross-resistance to non-beta-lactam antibiotic groups 
including quinolones, sulfamethoxazole, macrolides, 
aminoglycoside and lincomycin were frequently observed 
in MRSA isolates (Chambers 2001).
It has been reported that the MRSA infections are not 
limited to human but it can also infect domestic or farm 
animals such as horses, sheep, goat, and cattle (Saleha 
and Zunita 2010). MRSA has worldwide distribution but 
their frequency varies among various countries. The fre-
quency of MRSA in Pakistan and India has been shown 
to be high as compared to northern Europe (Anwar et al. 
2004). In Pakistan, the prevalence of methicillin resist-
ance in S. aureus has been observed with range from 
42 to 51 % (Akinkunmi and Lamikanra 2012). With the 
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increase of MRSA associated infections, the use of gly-
copeptides (vancomycin and teicoplanin) are also rising 
gradually. The irrational and indiscriminate use of glyco-
peptides results in the emergence of even low-level van-
comycin resistance in S. aureus. Such resistance, though 
rare, but it is an emerging threat because of its potential 
to disseminate rapidly (Perwaiz et  al. 2007). The pre-
sent study was designed to investigate the frequency of 
MRSA in Peshawar. Findings of the study will be helpful 
for devising an appropriate hospital antibiotic steward-
ship policy to reduce the chances of S. aureus associated 
infections in the area.
Methods
Ethical considerations
The current study was approved by departmental 
research ethics committee (DREC) of the Department of 
Microbiology, Kohat University of Science and Technol-
ogy, Kohat, Pakistan.
Samples description
The present study was carried out at Peshawar, the 
provincial capital of Khyber Pakhtunkhwa, Paki-
stan with confluence of local and Afghan refugee’s 
population. Clinical samples received at Pathology 
Department of Rehman Medical and Teaching Insti-
tute Peshawar, Pakistan from September 2012 to Sep-
tember 2013 were included in the study. An informed 
written consent was taken from patients to collect data 
regarding patient’s history, age and sex. In the present 
study different clinical samples were randomly col-
lected from patients who visited or admitted in the 
hospital during study duration. MRSA Infection origin 
(hospital acquired vs community acquired) was also 
determined. Hospital acquired infection is an infection 
that develops in the hospital and was not present at the 
time of admission while a community-acquired infec-
tion has been defined as an infection that was present 
at the time of admission in the hospital. This definition 
is as per CDC definition (Garner et  al. 1988; Salgado 
et al. 2003).
Culture and biochemical identification of S. aureus
Randomly collected clinical samples such as pus, fluid, 
blood, tissue and throat were processed for bacteria 
culturing followed by S. aureus identification based on 
Gram’s staining, culture characteristics and biochemical 
reactions such as Catalase, Coagulase and DNase (Per-
waiz et al. 2007). A total of 280 samples which were posi-
tive for S. aureus were further processed for antibiotic 
susceptibility to screen MRSA and MSSA.
Phenotypic based detection of MRSA
All confirmed S. aureus isolates were screened for methi-
cillin resistance using cefoxitin (Fox) disc and oxacillin 
resistant screening agar base medium (ORSB) method as 
described (Velasco et  al. 2005). Briefly, bacterial colony 
was picked up from overnight culture and inoculated into 
ORSAB medium followed by incubation at 35  °C for 24 
to 48  h. Presence of growth on ORSB was indicative of 
Oxacillin resistance. To check FOX resistance, bacterial 
lawn was prepared on Mueller–Hinton agar and FOX 
disk was placed on it, followed by incubation at 37 °C for 
overnight. Growth around the FOX disk was indicative of 
FOX resistance.
Molecular based detection of MRSA
Total DNA was extracted using Nucleospin® tissue 
genomic DNA kit according to the vendor protocol 
(Macherey–Nagel, Germany). The purified DNA was 
subjected to PCR based amplification of mecA gene 
using specific primers (Forward: 5′-AAAATCGATGGT 
AAAGGTTGGC-3′; Reverse 5′-AGTTCTGCAGTACC 
GGATTTGC-3′) as described earlier (Lee 2003). The 
amplified product was resolved on agarose gel electro-
phoresis and then visualized under UV transilluminator.
Antibiotic susceptibility assay
Antibiotic susceptibility test was carried out by disc dif-
fusion method (Velasco et  al. 2005). Bacterial overnight 
culture matched with 0.5 McFarland standards was inoc-
ulated on Mueller–Hinton agar plates and various anti-
biotic discs were placed followed by incubation at 37 °C 
for 24 h. Afterward, an antibiotic zone of inhibition was 
measured and interpreted as per the CLSI guidelines 
(CLSI 2012).
MIC determination of vancomycin against MRSA isolates 
by E‑test method
The MIC to vancomycin was performed by E-test method 
(Oxoid, England) and interpreted as per the CLSI guide-
lines (CLSI 2012).
Detection of inducible clindamycin resistance by D‑test
Inducible clindamycin resistance for MRSA isolates 
was checked by D-test as described earlier (Yilmaz et al. 
2007). Briefly, bacterial culture at 0.5 McFarland equiv-
alents was inoculated onto a MHA plate, followed by 
placement of erythromycin (15  mg) and clindamycin 
(2 mg) disks at 15 mm apart. Plate was then incubated at 
35 °C for overnight. A “D” shaped (blunted) clindamycin 
zone of inhibition towards erythromycin disc was inter-
preted as positive inducible clindamycin resistance.
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Statistical analysis
Numerical data was analyzed by Chi square test, odd 
ratio (OR) and 95  % confidence interval to determine 
statistical significance in the age, gender, infection origin 
(i.e. community vs. hospital) and antibiotic susceptibility 
pattern for MRSA and MSSA.
Results
Frequency of MRSA and MSSA
Out of total 280 S. aureus isolates, the frequency of 
MRSA and MSSA was 36.1  % (n  =  101) and 63.9  % 
(n  =  179) respectively. Both phenotypic (Cefoxitin disc 
and ORSAB) and Molecular (mecA detection) based 
MRSA screening methods showed similar results.
Specimen wise distribution showed that MRSA was 
most frequent in blood (48.7 %, OR 2.14), followed by flu-
ids (41.7 %, OR 1.27), and pus (36.7 %, OR 1.04). MSSA 
was most frequent in throat specimens (82.6 %) followed 
by tissue samples (80 %). (Table 1).
The frequency of MRSA was found to be 39.8 and 34 % 
for female and male respectively. On the other hand, the 
frequency of MSSA in male and female was 66.6 and 60 % 
respectively (Table 1).
Methicillin-resistant S. aureus infection was higher 
among the age group 50–59 years (60.71 %, OR 3.09), fol-
lowed by 20–29  years (47.5  %, OR 1.74), and 1–9  years 
(37.9  %, OR 1.10). MSSA infection was found higher 
among the age group 70–79  years (80  %), followed by 
60–69 years (75 %) (Table 1).
Among MRSA, the frequency of community acquired 
MRSA and hospital acquired MRSA was 42 % (n =  21) 
and 34.8 % (n = 80) respectively. The frequency of com-
munity acquired MSSA and hospital acquired MSSA was 
58 and 65.2 % respectively (Table 1).
Antibiotic susceptibility pattern of MRSA and MSSA
The current study showed that all MRSA isolates were 
100  % resistant to penicillin and cefoxitin; however 
entirely (100  %) susceptible to linezolid and vancomy-
cin followed by rifampicin (81.2  %), chloramphenicol 
(77.2 %), clindamycin (75.2 %), minocycline (67.3 %) and 
cotrimoxazole (65.3  %) (Table  2). The data was further 
investigated for multi-drugs resistance (MDR) MRSA 
and extended drugs resistant (XDR) MRSA as per CLSI 
(2012), which showed that 15.84  % and 6.93  % MRSA 
were observed to be MDR and XDR respectively. D-test 
Table 1 Prevalence of MRSA and MSSA isolated from Peshawar region of Khyber Pakhtunkhwa, Pakistan
N total numbers of S. aureus isolations; X2 Chi square; OR Odd ratio
p value <0.05 is considered as statistically significant
Variables S. aureus (N) MRSA n (%) MSSA n (%) X2 OR 95 % Confidence interval p value
Lower limit Upper limit
Age (years)
1–9 66 25 (37.9) 41 (62.1) 0.122 1.10 0.6257 1.9593 0.727
10–19 20 7 (35) 13 (65) 0.011 0.95 0.3666 2.4663 0.918
20–29 40 19 (47.5) 21 (52.5) 2.643 1.74 0.8872 3.425 0.104
30–39 34 11 (32.3) 23 (67.7) 0.232 0.83 0.3862 1.7796 0.631
40–49 22 6 (27.3) 16 (72.7) 0.802 0.64 0.2435 1.7003 0.371
50–59 28 17 (60.7) 11 (39.3) 8.193 3.09 1.3855 6.8953 0.004
60–69 40 10 (25) 30 (75) 2.481 0.54 0.2548 1.169 0.115
70–79 30 6 (20) 24 (80) 3.763 0.40 0.1609 1.0342 0.052
280 101 (36.1) 179 (63.9)
Sex
Male 182 62 (34) 120 (66) 0.906 0.78 0.4705 1.2984 0.341
Female 98 39 (39.8) 59 (60.2)
Specimen
Pus 120 44 (36.7) 76 (63.3) 0.032 1.04 0.6393 1.7119 0.857
Blood 82 40 (48.8) 42 (51.3) 8.122 2.14 1.2618 3.6258 0.004
Throat 46 8 (17.4) 38 (82.6) 8.329 0.32 0.1425 0.7147 0.004
Tissues 20 4 (20) 16 (80) 2.412 0.42 0.1365 1.2929 0.120
Fluids 12 5 (41.7) 7 (58.3) 0.170 1.27 0.3954 4.142 0.680
Type
Community acquired 50 21 (42) 29 (58) 0.93 1.36 0.7277 2.5334 0.330
Hospital acquired 230 80 (34.8) 150 (65.2)
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results revealed that 15.84 % (n = 16) of MRSA isolates 
were positive for inducible clindamycin resistance.
MSSA showed high resistance (100 %) to penicillin fol-
lowed by erythromycin (69.8 %) and doxycycline (54.7 %). 
In addition, MSSA showed 100 % sensitivity to amikacin, 
chloramphenicol, cefoxitin, linezolid, vancomycin and 
rifampicin (Table 2).
MIC for vancomycin
As vancomycin is drug of choice against MRSA, therefore 
MIC of vancomycin was checked against MRSA isolates 
(n = 79) which revealed that 42 isolates had MIC 2 µg/
ml followed by MIC 0.5 µg/ml (n = 12), 1 µg/ml (n = 12) 
2.5 µg/ml (n = 6), 4 µg/ml (n = 6) and 8 µg/ml (n = 1). 
Overall 7 isolates showed vancomycin MICs of 4 or 8 µg/
ml and thus were classified as VISA.
Discussion
Methicillin-resistant S. aureus has been reported as 
a major bacterial pathogen involved in both commu-
nity and hospitalized infections worldwide due to its 
increased virulence and continuous growing antibiotics 
resistance (Chambers and DeLeo 2009). In the present 
study we found 36.1  % frequency of MRSA among S. 
aureus isolates. A study conducted by Naeem et al. (2013) 
reported 31.5 % frequency of MRSA in Peshawar. There 
is continuous increase in the global prevalence of MRSA 
but generally frequency of MRSA in European countries 
Table 2 Antibiotics resistance pattern of MRSA and MSSA isolated from Peshawar region of Khyber Pakhtunkhwa, Paki-
stan
p value <0.05 is considered as statistically significant
Antimicrobial drugs Drug susceptibility MRSA n (%) MSSA n (%) p value
Penicillin (10 µg) Susceptible 0 (0) 0 (0) 1
Resistant 101 (100) 179 (100)
Amikacin (30 µg) Susceptible 52 (51.5) 179 (100) <0.0001
Resistant 49 (48.5) 0 (0)
Chloramphenicol (30 µg) Susceptible 78 (77.2) 179 (100) <0.0001
Resistant 23 (22.8) 0 (0)
Ciprofloxacin (5 µg) Susceptible 20 (19.8) 137 (76.5) <0.0001
Resistant 81 (80.2) 42 (23.7)
Cefoxitin (30 µg) Susceptible 0 (0) 179 (100) <0.0001
Resistant 101 (100) 0 (0)
Erythromycin (15 µg) Susceptible 01 (0.99) 54 (30.2) <0.0001
Resistant 100 (99.01) 125 (69.8)
Gentamicin (10 µg) Susceptible 44 (43.6) 167 (93.3) <0.0001
Resistant 57 (56.4) 12 (6.7)
Clindamycin (2 µg) Susceptible 76 (75.2) 177 (98.9) <0.0001
Resistant 25 (24.8) 2 (1.1)
Minocycline (30 µg) Susceptible 68 (67.3) 115 (64.3) 0.603
Resistant 33 (32.7) 64 (35.7)
Doxycycline (30 µg) Susceptible 59 (58.4) 81 (45.3) 0.034
Resistant 42 (41.6) 98 (54.7)
Cotrimoxazole (1.25/23.75 µg) Susceptible 67 (65.3) 167 (93.3) <0.0001
Resistant 34 (33.7) 12 (6.7)
Linezolid (30 µg) Susceptible 101 (100) 179 (100) 1
Resistant 0 (0) 0 (0)
Fusidic acid (10 µg) Susceptible 60 (59.4) 148 (82.7) <0.0001
Resistant 41 (40.6) 31 (17.3)
Rifampicin (5 µg) Susceptible 82 (81.2) 179 (100) <0.0001
Resistant 19 (18.8) 0 (0)
Vancomycin (30 µg) Susceptible 101 (100) 179 (100) 1
Resistant 0 (0) 0 (0)
Moxifloxacin (5 µg) Susceptible 15 (14.9) 174 (97.2) <0.0001
Resistant 86 (85.1) 5 (2.8)
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is lesser as compared to other parts of the world. The 
reason may be the implementation of strict antibiotic 
prescribing policies and infection control practices in 
European countries (Askari et al. 2012).
In the present study MRSA was most frequent in blood 
(48.7 %); similar finding was also observed earlier (Has-
san et  al. 2014). No statistically significant differences 
were found regarding frequency of MRSA in gender or 
group of infection origin (hospital acquired vs commu-
nity acquired). MRSA infection was higher among the 
age group 50–59  years (60.71  %), which is in line with 
another study conducted in Pakistan which reported high 
prevalence of MRSA in age group +44 years (Khan et al. 
2014).
The multi-drug resistance in MRSA isolates has been 
a major problem worldwide which leads to ineffective 
therapy and increase in treatment expenses (Köck et  al. 
2010). The present study highlighted that high number of 
MRSA were multi-drug resistant which is in line with the 
previous findings which reported high rate of multi-drug 
resistance in MRSA (Tiwari et al. 2008; Khan et al. 2013).
We have found that all MRSA isolates tested in the pre-
sent study were fully sensitive to vancomycin so it may be 
used as the drug of choice for treating multidrug-resist-
ant MRSA infections. Similar findings were reported by 
various previous studies (Singh et  al. 2013; Sipahi et  al. 
2013; Bhatt et al. 2014; Chelliah et al. 2014). In addition, 
all isolates were sensitive to linezolid which is in line with 
other studies (Sipahi et  al. 2013; Vijayamohan and Nair 
2014). Linezolid has been approved by FDA for treating 
MRSA infection, so linezolid could be a possible alterna-
tive of vancomycin (Micek 2007). Previous study showed 
that patient treated with linezolid had significantly higher 
survival rate than those treated with vancomycin (Wun-
derink et  al. 2003). All MRSA isolates were resistant to 
cefoxitin which is in line with other studies (Wang et al. 
2013; Ahmad et al. 2015). MRSA resistance to quinolones 
(ciprofloxacin) was also found to be very high (80.19 %) 
in the current study. This correlates with an earlier find-
ing where it has been shown that MRSA was 86.59  % 
resistant to ciprofloxacin (Pandya et al. 2014).
The MIC profile revealed 7 (8.97  %) MRSA isolates 
as VISA. A previous study conducted at Pakistan also 
reported 13  % frequency of VISA using MIC by E test 
(Hakim et  al. 2007). In the current study, we observed 
15.84  % inducible clindamycin resistance in MRSA iso-
lates which is in line with other studies (Yilmaz et  al. 
2007; Maninder et al. 2013). The high frequency of induc-
ible clindamycin resistance in the present study and 
many other studies suggest that D-test should be adopted 
as routine practice in diagnostic microbiology to avoid 
clindamycin therapy failure (Maninder et al. 2013).
Conclusion
The present study highlighted high proportion of MRSA 
and their multidrug resistance in clinical settings at 
Peshawar. The MDR MRSA is a potential threat to the 
public health at Peshawar as this bug can disseminate in 
community causing severe clinical conditions. Vancomy-
cin and linezolid could be the drugs of choice in treat-
ing MRSA infection. Furthermore, MIC of vancomycin 
should be performed routinely to screen out VISA. In 
depth studies are needed in different geographical areas 
of the Pakistan to better understand the epidemiology 
and molecular mechanisms of drug resistance in MRSA.
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